Safety, tolerability, and immunogenicity of a SARS-CoV-2 recombinant spike RBD protein vaccine: A randomised, double-blind, placebo-controlled, phase 1-2 clinical trial (ABDALA Stu... by Francisco Hernández-Bernal, Maria C. Ricardo-Cobas, Yenima Martín-Bauta, Zadis Navarro-Rodríguez, Marjoris Piñera-Martínez, Joel Quintana-Guerra, Karen Urrutia-Pérez, Klaudia Urrutia-Pérez, Cristina O. Chávez-Chong, Jorge L. Azor-Hernández, José L. Rodríguez-Reinoso, Leonardo Lobaina-Lambert, Elizabeth Colina-Ávila, Jacqueline Bizet-Almeida, Jeniffer Rodríguez-Nuviola, Sergio del Valle-Piñera, Mayara Ramírez-Domínguez, Elisangela Tablada-Ferreiro, Marel Alonso-Valdés, Gilda Lemos-Pérez, Gerardo E. Guillén-Nieto, Ariel Palenzuela-Díaz, Enrique Noa-Romero, Miladys Limonta-Fernández, Juan M. Fernández-Ávila, Nabil A. Ali-Mros, Lianne del Toro-Lahera, Rossana Remedios-Reyes, Marta Ayala-Ávila, Verena L. Muzio-González

Get full text